Röjdmark S, Berg A, Rössner S, Wetterberg L
Department of Internal Medicine II, Södersjukhuset, Stockholm, Sweden.
Clin Endocrinol (Oxf). 1991 Jul;35(1):61-5. doi: 10.1111/j.1365-2265.1991.tb03497.x.
The purpose was to investigate whether the function of the pinealocytes is changed in patients with disturbed metabolic rate or in subjects with marked obesity.
Venous blood was sampled every second hour between 1800 and 0800 h, and urine collected between 2200 and 0700 h.
Eight patients with thyrotoxicosis, six with primary hypothyroidism, eight with maturity-onset obesity, and 12 healthy controls were included in the study.
Peak serum melatonin values during the night, total nocturnal melatonin secretion (estimated by melatonin incremental areas), and urinary excretion of melatonin were determined in each participant.
Patients with hypothyroidism were found to have higher peak serum melatonin values, total nocturnal melatonin secretion, and urinary excretion of melatonin than normal individuals (Peak melatonin values: 0.55 +/- 0.13 vs 0.27 +/- 0.04 nmol/l, respectively; P less than 0.05. Melatonin incremental areas: 3.38 +/- 0.80 vs 1.45 +/- 0.26 nmol/l h; P less than 0.05. Melatonin excretion: 0.140 +/- 0.023 vs 0.081 +/- 0.013 nmol/9 h; P less than 0.05). Neither of these values differed significantly from the normal in patients with thyrotoxicosis or obesity. Although thyrotoxic patients thus released a normal amount of melatonin during the night, their melatonin secretion peak was phase advanced (melatonin secretion peak appearing at 1.1 +/- 0.5 h in thyrotoxic, and at 3.4 +/- 0.5 h in normal participants; P less than 0.01). No such phase shifts were seen in patients with obesity or hypothyroidism.
These findings imply that both hypothyroid and thyrotoxic patients have disturbed pineal function, which is not the case in patients with obesity. The mechanism underlying these observations remains to be elucidated.
本研究旨在调查代谢率紊乱的患者或明显肥胖的受试者的松果体细胞功能是否发生改变。
于18:00至08:00期间,每两小时采集一次静脉血样;于22:00至07:00期间收集尿液样本。
本研究纳入了8例甲状腺毒症患者、6例原发性甲状腺功能减退患者、8例成年型肥胖患者以及12名健康对照者。
测定每位参与者夜间血清褪黑素峰值、夜间褪黑素总分泌量(通过褪黑素增量面积估算)以及尿褪黑素排泄量。
发现甲状腺功能减退患者的血清褪黑素峰值、夜间褪黑素总分泌量以及尿褪黑素排泄量均高于正常个体(褪黑素峰值分别为:0.55±0.13与0.27±0.04 nmol/L;P<0.05。褪黑素增量面积:3.38±0.80与1.45±0.26 nmol/L·h;P<0.05。褪黑素排泄量:0.140±0.023与0.081±0.013 nmol/9 h;P<0.05)。甲状腺毒症患者或肥胖患者的这些值与正常个体相比均无显著差异。尽管甲状腺毒症患者夜间释放的褪黑素量正常,但其褪黑素分泌峰值提前(甲状腺毒症患者的褪黑素分泌峰值出现在1.1±0.5小时,正常参与者为3.4±0.5小时;P<0.01)。肥胖或甲状腺功能减退患者未出现此类相位变化。
这些发现表明,甲状腺功能减退和甲状腺毒症患者均存在松果体功能紊乱,而肥胖患者并非如此。这些观察结果背后的机制仍有待阐明。